Viewing nowCombinationAliem Tablets 10/5 mg (Empagliflozin, Linagliptin)
Empagliflozin Amorphous 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.

MFDS item code 202502161 · Approved 2025.08.20 · Insurance code 656005860
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication helps patients with type 2 diabetes effectively control their blood sugar levels while managing diet and exercise. The two ingredients, empagliflozin and linagliptin, work together to improve blood sugar levels. Therefore, this medication is used for blood sugar management in type 2 diabetes.
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this drug may be increased to 25/5 mg once daily. Patients switching to this drug from combination therapy with empagliflozin and linagliptin should receive their previous doses. This drug may be taken with or without food. Swallow the tablet whole. If a dose of this drug is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dosage adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or greater. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Since this drug has not been studied in patients with severe hepatic impairment, its use is not recommended. Elderly patients No dosage adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is a diabetes treatment composed of two ingredients, empagliflozin and linagliptin. First, this medication should not be used by individuals who are allergic to empagliflozin, linagliptin, or any other components included in this medication, those with type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. It is important for individuals with reduced kidney function to regularly check their kidney function, as this may alter the effects of the medication. Patients with mild to moderate heart failure should use this medication with caution, and it is not recommended for patients with severe heart failure. Linagliptin may cause acute pancreatitis, so if severe abdominal pain persists, discontinue use immediately and consult a doctor. Additionally, this medication may rarely cause a skin condition called bullous pemphigoid that leads to blisters, so notify a physician immediately if any skin abnormalities occur. The most common side effect is a urinary tract infection; other potential side effects include hypoglycemia, pancreatitis, allergic reactions, etc. Particularly, the risk of hypoglycemia may increase when taken with insulin or sulfonylureas, hence caution is advised. This medication can cause dehydration or low blood pressure, so older adults or patients with low blood pressure should use it carefully. The risk of urinary tract infections and genital fungal infections may increase, so prompt treatment is necessary if any infection symptoms arise. It is advisable for women who are pregnant or planning to become pregnant to avoid using this medication, and breastfeeding individuals are recommended to discontinue breastfeeding. Safety and efficacy have not been established in children under 18 years of age, therefore, it is advisable not to use it in this age group. In case of overdose, notify healthcare professionals immediately and receive the necessary treatment. Store this medication out of reach of children, and keep it in its original container to ensure safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Furthermore, it is safe to store the medication at room temperature, i.e., between 1 degree and 30 degrees Celsius, avoiding overly hot or cold areas.
Flat on both sides with sharp edges, light yellow triangular film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin Amorphous 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
CombinationEmpagliflozin Amorphous 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.
CombinationEmpagliflozin Amorphous 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Aprogen Biologics Co., Ltd.
CombinationLinagliptin Micronized 5mg · Empagliflozin Amorphous 10mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationLinagliptin Micronized 5mg · Empagliflozin Amorphous 25mg
Tablet · Prescription medication · Combination
Korea Prime Pharma Co., Ltd.
CombinationLinagliptin Micronized 5mg · Empagliflozin Amorphous 25mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.
CombinationEmpagliflozin Amorphous 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Alico Pharmaceutical Co., Ltd.
Linagliptin Micronized 5mg · Empagliflozin Amorphous 25mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.